Recent advances push Big Tech closer to the Q-Day danger zone

As the joke goes, CRQC has been 10 to 20 years away for the past three decades. While the recent research suggests that ...
Microsoft

Building your cryptographic inventory: A customer strategy for cryptographic posture management

Learn how to build a comprehensive cryptographic inventory and strengthen quantum‑safe readiness using Microsoft Security ...
pharmaphorum

J&J's Tecvayli claims third national priority FDA approval

Johnson & Johnson's Tecvayli has been approved as part of a combination regimen with its Genmab-partnered Darzalex Faspro as a second-line therapy for relapsed or refractory multiple myeloma, just 55 ...